According to JPND, the EU joint program for global research initiatives aimed at tackling the challenges of neurodegenerative diseases, neurodegenerative diseases are a group of disorders that affect the neurons in human brain. When neurons get damaged owing to the effect of neurodegenerative diseases such as Alzheimer’s, Parkinson’s, or Huntington’s disease, they cannot be replaced, as neurons don’t reproduce like other human cells.
Thus, neurodegenerative diseases are debilitating and incurable conditions that result in progressive degeneration of neurons and lead to problems with mental functioning and movement. The prevalence of these conditions is on a constant rise across the globe, yet there is a general lack of effective therapies to treat the same.
The report is a detailed analysis of the different treatment mechanisms currently available in the market for treating neurodegenerative diseases. It examines the various aspects of the market in great detail and analyzes all segments from a global as well as regional standpoint. The impact of the regulatory framework, policies, and key regulations on a variety of business decisions is also studied in the report.
The report comprises the most insightful data delivered by analyzing data gathered with the help of a number of primary and secondary research methodologies, and insights from industry experts.
The report states that the market for treatments of neurodegenerative diseases is being driven by the rising awareness about mental disorders and a constant rise in research and development activities aimed at finding effective therapies for treating them. However, the complex nature of these diseases and the lack of knowledge about their causative factors in most cases hinder the advancement of research and development into effective treatment methods. The medications currently available in the market for the cure of neurodegenerative diseases only help in alleviating symptoms, rather than curing the disease itself. Thus, the market holds huge scope for future growth.
The report categorizes the market for treatments of neurodegenerative disorders broadly into progressive dementia, movement disorders, and dementia with other neurological abnormalities. Of these segments, the market segment of progressive dementia accounted for the largest share in the global treatments for neurodegenerative disorders market. Dementia with other neurological disorders followed the market segment of progressive dementia.
The report segments the market on the basis of the diseases that come under the umbrella term of neurodegenerative disorders and have the most prominent impact on the overall market. This segment of the report examines the markets for Huntington’s disease, corticobasal ganglionic degeneration, Alzheimer’s disease, progressive supranuclear palsy, Pick’s disease, Hallervorden-Spatz disease, multiple system atrophy, and Lewy body dementia. On the basis of geography, the market is segmented into North America, Asia Pacific, Europe, and the Rest of the World (RoW).
Global Treatments for Neurodegenerative Disorders Market: Key Vendors
The report also presents a detailed overview of the competitive landscape of the market with the help of detailed business profiles of some of the key companies operating in the market. Looking at the challenging nature of the field of operation, it is no wonder that most of the world’s best pharmaceutical companies have operations dedicated to research and treatment of neurodegenerative disorders. Some of these are Abbott Laboratories, Baxter International, Inc., Roche Holding Ltd., Colucid Pharmaceuticals, Inc., Cipla Ltd., Glenmark Generics Ltd., Daiichi Sankyo Co. Ltd., Acorda Therapeutics, Inc., Neuro-Hitech, Inc., Boehringer Ingelheim Ltd., and Cellzome AG.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
With a robust experience in creating exceptional market reports, Transparency Market Research has emerged as one of the trusted market research companies among a large number of stakeholders and CXOs. Every report at Transparency Market Research goes through rigorous research activity in every aspect. The researchers at TMR keep a close watch on the market and extract beneficial growth-boosting points. These points help the stakeholders to strategize their business plans accordingly.
TMR researchers conduct exhaustive qualitative and quantitative research. This research involves taking inputs from the experts in the market, focused attention on recent developments, and others. This method of research makes TMR stand out from other market research firms.
Here's how Transparency Market Research helps the stakeholders and CXOs through the reports:
Inculcation and Evaluation of Strategic Collaborations: The TMR researchers analyze recent strategic activities like mergers, acquisitions, partnerships, collaborations, and joint ventures. All the information is compiled and included in the report.
Perfect Market Size Estimations: The report analyzes the demographics, growth potential, and capability of the market through the forecast period. This factor leads to the estimation of the market size and also provides an outline about how the market will retrieve growth during the assessment period.
Investment Research: The report focuses on the ongoing and upcoming investment opportunities across a particular market. These developments make the stakeholders aware of the current investment scenario across the market.
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.